Joint Formulary & PAD

Strontium ranelate - Osteoporosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Strontium ranelate
Indication :
Osteoporosis
Group Name :
Keywords :
Brand Names Include :
Aristo
Important Information :

Rheumatology only. Reserved for severe osteoporosis in patients for whom other treatment options are not suitable.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5

Other Indications

Below are listed other indications that Strontium ranelate is used to treat.

  • No records returned.

Committee Recommendations (1)

Strontium ranelate (Aristo) granules for oral suspension are a specilalist treament option (RED status) for severe osteoporosis in patients who are intolerant to or contraindicated for other therapies. See Osteoporosis Assessment and Treatment Guidelines below.

The Osteoporosis guidelines have been reviewed and updated.
The guidelines are supported by two algorithms which have been extracted from the guideline and provided as separate documents (below) for ease of use:
Algorithm 1 - Treatment Pathway for adults
Algorithm 2 - Review of Long-term Bisphosphonate Therapy